Figure S2. Levels of tau-13-immunoreactive Δtau314 proteins, following normalization to levels of tau-5-reactive proteins (T-tau (WB)) revealed by direct Western blotting, are higher in HD patients than non-HD individuals. The gene discussed is MAPT; the disease is Huntington disease.